Skip to content

Pharmacological Recruitment of Endogenous Neural Precursors to Promote Pediatric White Matter Repair: Establishing Correlations Between Visual Outcomes, Saccadic Function and MEG Oscillations in Children With Demyelinating Disorders in Comparison to Healthy Control Children

Pharmacological Recruitment of Endogenous Neural Precursors to Promote Pediatric White Matter Repair: Establishing Correlations Between Visual Outcomes, Saccadic Function and MEG Oscillations in Children With Demyelinating Disorders in Comparison to Healthy Control Children

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03010826
Enrollment
78
Registered
2017-01-05
Start date
2016-12-31
Completion date
2018-11-16
Last updated
2020-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Demyelinating Disease

Brief summary

The neural circuits in our brains require a layer of insulation in order to transmit signals in a rapid and efficient fashion. This insulation is called White Matter and is comprised of a specific type of brain cell called an oligodendrocytes. Damage to brain white matter occurs following injury and in disorders like Multiple Sclerosis and results in sensory, motor, and cognitive problems. Currently there are no effective medical therapies to promote brain repair and reduce disability following damage to white matter. In this project, we hope to change the situation by encouraging the brain itself to generate new oligodendrocytes and thus new white matter. Our first step is to find measures sensitive to white matter growth.

Interventions

None listed

Sponsors

The Hospital for Sick Children
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
5 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Experienced a demyelinating event (Only applicable to patient subjects) * Between the ages of 5 years to 18 years and 11 months of age * Has either English as his or her native language or has had at least two years of schooling in English

Exclusion criteria

* Children with non-demyelinating etiologies of white matter dysfunction (i.e., metabolic disorders, vasculitis, and non-specific MRI abnormalities * Is younger than 5 years of age * Is 18 years and 11 of age or older * Has a prior history of traumatic brain injury, neurological disorder, cerebral palsy, developmental delay, or learning disability * Requires sedation for brain scanning * Is claustrophobic, as brain scanning requires children to enter a tunnel in the MRI machine

Design outcomes

Primary

MeasureTime frameDescription
Neuronal responses during pro/anti-saccade eye movements60 minutesVideo-based eye tracking monocularly in the MEG and binocularly outside the MEG
Electrical potentials initiated by brief visual stimuli10 minutesVisual Evoked Potentials (VEP)
MRI scans of the brain, including Diffusion Tensor Imagine (DTI)90 minutes
Neurocognitive Testing90 minutesComputerized Penn Neurocognitive Battery
High contrast visual acuity10 minutes
Low contrast visual acuity; colour vision; visual fields testing; OCT testing;10 minutes
Colour vision testing10 minutes
Visual fields testing20 minutes
Optical coherence tomography (OCT)25 minutes
Neurological Exam - Standard physical exam performed by neurologist to determine the Expanded Disability Status Scale (EDSS) score.20 minutes
Clinical Interview10 minutes

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026